ETAP-LAB is an independent, preclinical CRO that provides efficacy testing and preclinical pharmacology services to the pharmaceutical, biotechnology, and nutraceutical industries.
ETAP-LAB’s services are designed to support drug discovery phases ranging from in vitro lead optimization to non-GLP animal testing (POC, PK/PD, non-regulatory safety pharmacology), to evaluate the efficacy and safety of your drug candidates (small molecules, antibodies, biotherapy and cell therapy), medical devices and nutraceuticals.
Our areas of preclinical expertise
A CRO at your service for over 35 years
ETAP-LAB advises its clients and evaluates their therapeutic innovations based on a reliable and cost-effective approach, with a comprehensive and validated portfolio of translational in vitro andin vivo models. Why choose our company?
- Personalized and responsive customer service.
We respond to your requests within 48 hours.
- Fast and flexible access to a portfolio of validated and innovative models.
Studies are conducted by our expert scientists and efficient technical team to ensure a competitive cost-performance ratio.
- Precise schedule and traceability.
Each study is supervised by a designated and accessible Study Director; strict adherence to the defined study plan and schedule to produce high-quality deliverables in accordance with our quality assurance system.
- Clear and comprehensive deliverables.
After presentation and discussion of the results with the sponsor, a standalone study report is published.
- Proven clinical predictability.
For over 35 years, our studies have contributed to the successful market launch of numerous healthcare products designed by our customers.
ETAP-LAB is committed to improving selection, and accelerating the development of your therapeutic innovations, while providing an efficient, cost-effective service.
Cutting-edge services for robust data.
Our values deliver high-quality services that go above and beyond
Excellence, Transparency, Agility et Proximity : find out more about the E.T.A.P. system that guides our daily practices, so that we can overcome the future challenges in medicine by your side and transform your innovations into therapeutic solutions.
We are committed to delivering
the best possible results
Latest news
Boost Your CNS Candidate Selection – Appealing Discount on Screening Campaigns.
SfN NEUROSCIENCE 2025 – Empower your drug candidates with our translational preclinical models
